No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
JW Pharmaceutical Corporation operates as a global entity, actively involved in the creation, production, and distribution of a diverse range of pharmaceuticals and medical provisions. Its market reach extends internationally, with a significant presence in Japan. The company's extensive portfolio encompasses treatments across numerous therapeutic areas, including cardiovascular, gastrointestinal, urinary, and central nervous system health. It also addresses infectious diseases (such as those requiring antibiotics and antifungals), diabetes, obstetric and gynecological conditions, renal disorders, and respiratory ailments. Additionally, their offerings include medications for anemia, rheumatic arthritis, various cancers, anesthesia, antidotes, amino acid formulations, and Total Parenteral Nutrition (TPN). Founded in 1945, JW Pharmaceutical's corporate headquarters are located in Seoul, South Korea.
www.jw-pharma.co.krNo one on the platform currently holds 001067.KS.
No tracked institution reports a position in 001067.KS as of their last filing.
No one on the platform has traded 001067.KS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 15.8% | 11.5% | — | — | — | |
| Rev. Growth % | 7.7% | 7.2% | ||||
| Profit Margin % | 8.0% | 5.3% | 1.8% | |||
| Free Cash Flow Margin % | 10.9% | 6.3% | 6.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $849.2B | +7.6% | $3670.00 | $3670.00–$3670.00 | — | 1 |
| 2027 | $891.0B | +4.9% | $3982.00 | $3982.00–$3982.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 001067.KSJW Pharmaceutical Corporation | $48350.00 | -0.10% | $447.2B | — |
| 000105.KSYuhan Corporation | $68200.00 | +0.59% | $5.93T | — |
| 001060.KSJW Pharmaceutical Corporation | $27100.00 | +0.00% | $625.8B | — |
| 001065.KSJW Pharmaceutical Corporation | $22350.00 | -0.22% | $394.3B | — |
| 007575.KSIlyang Pharmaceutical Co.,Ltd | $7540.00 | -0.13% | $154.0B | — |
| 019175.KSShinpoong Pharmaceutical Co.,Ltd | $14580.00 |
Source: Financial Modeling Prep · peers by sector/industry
| -3.76% |
| $386.3B |
| — |
| CGCCanopy Growth Corporation | $0.92 | -1.95% | $388M | — |